Medicamen Biotech Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Rajesh Madan
Chief executive officer
₹5.7m
Total compensation
CEO salary percentage | n/a |
CEO tenure | 8yrs |
CEO ownership | 1.2% |
Management average tenure | 6yrs |
Board average tenure | 8.3yrs |
Recent management updates
Recent updates
What Medicamen Biotech Limited's (NSE:MEDICAMEQ) 28% Share Price Gain Is Not Telling You
May 21More Unpleasant Surprises Could Be In Store For Medicamen Biotech Limited's (NSE:MEDICAMEQ) Shares After Tumbling 26%
Mar 17Medicamen Biotech (NSE:MEDICAMEQ) Will Pay A Dividend Of ₹1.00
Sep 13Why Medicamen Biotech's (NSE:MEDICAMEQ) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 19There's Reason For Concern Over Medicamen Biotech Limited's (NSE:MEDICAMEQ) Price
Dec 03CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | ₹127m |
Sep 30 2023 | n/a | n/a | ₹133m |
Jun 30 2023 | n/a | n/a | ₹154m |
Mar 31 2023 | ₹6m | n/a | ₹148m |
Dec 31 2022 | n/a | n/a | ₹137m |
Sep 30 2022 | n/a | n/a | ₹137m |
Jun 30 2022 | n/a | n/a | ₹143m |
Mar 31 2022 | ₹5m | n/a | ₹149m |
Dec 31 2021 | n/a | n/a | ₹158m |
Sep 30 2021 | n/a | n/a | ₹150m |
Jun 30 2021 | n/a | n/a | ₹140m |
Mar 31 2021 | ₹5m | ₹5m | ₹121m |
Dec 31 2020 | n/a | n/a | ₹110m |
Sep 30 2020 | n/a | n/a | ₹116m |
Jun 30 2020 | n/a | n/a | ₹123m |
Mar 31 2020 | ₹5m | ₹5m | ₹133m |
Dec 31 2019 | n/a | n/a | ₹136m |
Sep 30 2019 | n/a | n/a | ₹124m |
Jun 30 2019 | n/a | n/a | ₹123m |
Mar 31 2019 | ₹5m | ₹5m | ₹120m |
Compensation vs Market: Rajesh's total compensation ($USD67.98K) is above average for companies of similar size in the Indian market ($USD39.52K).
Compensation vs Earnings: Rajesh's compensation has been consistent with company performance over the past year.
CEO
Rajesh Madan
8yrs
Tenure
₹5,664,000
Compensation
Mr. Rajesh Madan, B. Pharma, has been the Chief Executive Officer at Medicamen Biotech Ltd. since May 30, 2016. He possesses broad experience in the Pharmaceutical manufacturing and exports.He is involved...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 8yrs | ₹5.66m | 1.21% ₹ 82.7m | |
Chief Financial Officer | 5.8yrs | ₹1.39m | no data | |
Compliance Officer & Company Secretary | 6.3yrs | ₹649.00k | no data | |
Head of Operations | 2.3yrs | no data | no data |
6.0yrs
Average Tenure
Experienced Management: MEDICAMEQ's management team is seasoned and experienced (6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Non-Executive Non-Independent Director | 8.3yrs | no data | 1.6% ₹ 108.9m | |
Non-Executive Chairman | 8.4yrs | no data | no data | |
Non-Executive Non-Independent Director | 8.4yrs | no data | no data | |
Non-Executive Non-Independent Director | 8.4yrs | no data | no data | |
Non-Executive Non-Independent Director | 5.3yrs | no data | no data | |
Independent Non-Executive Director | 8.3yrs | no data | no data | |
Independent Non-Executive Director | 8.4yrs | no data | no data | |
Independent Non-Executive Woman Director | 5.5yrs | no data | no data | |
Independent Non-Executive Woman Director | 5.3yrs | no data | no data | |
Independent Non-Executive Director | 5yrs | no data | no data |
8.3yrs
Average Tenure
60.5yo
Average Age
Experienced Board: MEDICAMEQ's board of directors are considered experienced (8.3 years average tenure).